Log in

Integrated BioPharma Stock Price, Forecast & Analysis (OTCMKTS:INBP)

+0.01 (+2.00 %)
(As of 11/21/2019 08:18 AM ET)
Today's Range
Now: $0.26
50-Day Range
MA: $0.22
52-Week Range
Now: $0.26
Volume7,500 shs
Average Volume12,817 shs
Market Capitalization$7.54 million
P/E Ratio3.25
Dividend YieldN/A
Integrated Biopharma, Inc., together with its subsidiaries, manufactures, distributes, markets, and sells vitamins, nutritional supplements, and herbal products primarily in the United States, Luxembourg, and Canada. It operates through three segments: Contract Manufacturing, Branded Proprietary Products, and Other Nutraceutical Businesses. The Contract Manufacturing segment manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers, and specialized health-care providers. The Branded Proprietary Products segment distributes healthful nutritional products for sale through mass market, grocery, drug, and vitamin retailers under the Naturally Noni, Peaceful Sleep, Green Envy, FiberCal, and Wheatgrass brands, as well as other branded proprietary nutraceutical products. The Other Nutraceutical Businesses segment sells private label vitamin and nutritional supplement products, and healthful nutritional products through the Internet; and distributes fine natural botanicals, including multi minerals, as well as raw materials. This segment also provides warehousing and fulfilment services. The company was formerly known as Integrated Health Technologies, Inc. Integrated Biopharma, Inc. was founded in 1979 and is based in Hillside, New Jersey.

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Current SymbolOTCMKTS:INBP



Sales & Book Value

Annual Sales$49.98 million
Cash Flow$0.08 per share
Book Value$0.06 per share


Net Income$1.69 million


Market Cap$7.54 million
Next Earnings Date11/22/2019 (Estimated)
OptionableNot Optionable

Receive INBP News and Ratings via Email

Sign-up to receive the latest news and ratings for INBP and its competitors with MarketBeat's FREE daily newsletter.

Integrated BioPharma (OTCMKTS:INBP) Frequently Asked Questions

What is Integrated BioPharma's stock symbol?

Integrated BioPharma trades on the OTCMKTS under the ticker symbol "INBP."

When is Integrated BioPharma's next earnings date?

Integrated BioPharma is scheduled to release their next quarterly earnings announcement on Friday, November 22nd 2019. View Earnings Estimates for Integrated BioPharma.

Has Integrated BioPharma been receiving favorable news coverage?

Headlines about INBP stock have been trending positive this week, InfoTrie reports. The research firm identifies positive and negative news coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Integrated BioPharma earned a daily sentiment score of 3.0 on InfoTrie's scale. They also gave news stories about the company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an effect on the company's share price in the immediate future. View News Stories for Integrated BioPharma.

Who are some of Integrated BioPharma's key competitors?

What other stocks do shareholders of Integrated BioPharma own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Integrated BioPharma investors own include Tilray (TLRY), Cancer Genetics (CGIX), Ares Capital (ARCC) and AGNC Investment (AGNC).

Who are Integrated BioPharma's key executives?

Integrated BioPharma's management team includes the folowing people:
  • Mr. E. Gerald Kay, Exec. Chairman (Age 83)
  • Ms. Riva Kay Sheppard, Co-CEO & Director (Age 52)
  • Ms. Christina Kay, Co-CEO & Director (Age 49)
  • Ms. Dina L. Masi, Sr. VP, CFO & Sec. (Age 58)
  • Mr. Jamie E. Levey, Head of Investor Relations

How do I buy shares of Integrated BioPharma?

Shares of INBP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Integrated BioPharma's stock price today?

One share of INBP stock can currently be purchased for approximately $0.26.

How big of a company is Integrated BioPharma?

Integrated BioPharma has a market capitalization of $7.54 million and generates $49.98 million in revenue each year. Integrated BioPharma employs 128 workers across the globe.View Additional Information About Integrated BioPharma.

What is Integrated BioPharma's official website?

The official website for Integrated BioPharma is http://www.integratedbiopharma.com/.

How can I contact Integrated BioPharma?

Integrated BioPharma's mailing address is 225 LONG AVENUE BUILDING 15, HILLSIDE NJ, 07205. The company can be reached via phone at 888-319-6962.

MarketBeat Community Rating for Integrated BioPharma (OTCMKTS INBP)

Community Ranking:  3.2 out of 5 (star star star)
Outperform Votes:  54 (Vote Outperform)
Underperform Votes:  31 (Vote Underperform)
Total Votes:  85
MarketBeat's community ratings are surveys of what our community members think about Integrated BioPharma and other stocks. Vote "Outperform" if you believe INBP will outperform the S&P 500 over the long term. Vote "Underperform" if you believe INBP will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 11/21/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel